Publicacions

Immunophenotypic, Cytogenetic, and Mutational Characterization of Cell Lines Derived from Myelodysplastic Syndrome Patients After Progression to Acute Myeloid Leukemia

Palau, A; Mallo, M; Palomo, L; Rodriguez-Hernandez, I; Diesch, J; Campos, D; Granada, I; Junca, J; Drexler, HG; Sole, F; Buschbeck, M

GENE CHROMOSOME CANC

Leukemia cell lines have been widely used in the hematology field to unravel mechanistic insights and to test new therapeutic strategies. Myelodysplastic syndromes (MDS) comprise a heterogeneous group of diseases that are characterized by ineffective hematopoiesis and frequent progress to acute myeloid leukemia (AML). A few cell lines have been established from MDS patients after progression to AML but their characterization is incomplete. Here we provide a detailed description of the immunophenotypic profile of the MDS-derived cell lines SKK-1, SKM-1, F-36P; and MOLM-13. Specifically, we analyzed a comprehensive panel of markers that are currently applied in the diagnostic routine for myeloid disorders. To provide high-resolution genetic data comprising copy number alterations and losses of heterozygosity we performed whole genome single nucleotide polymorphism-based arrays and included the cell line OHN-GM that harbors the frequent chromosome arm 5q deletion. Furthermore, we assessed the mutational status of 83 disease-relevant genes. Our results provide a resource to the MDS and AML field that allows researchers to choose the best-matching cell line for their functional studies. (C) 2016 Wiley Periodicals, Inc.

Obre a Pubmed